S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SGMO Sangamo Therapeutics Inc

0.823

-0.0026 (-0.31%)

Oct 11 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Sangamo Therapeutics Charts.

Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Sangamo Therapeutics Charts.

Sangamo Therapeutics Inc News

Form 8-K - Current report
Friday 4 October 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 27 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 15 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (2 months ago) • Edgar (US Regulatory)

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
Tuesday 6 August 2024 (2 months ago) • Business Wire

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases
Tuesday 6 August 2024 (2 months ago) • Business Wire

Sangamo Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
Tuesday 30 July 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 24 July 2024 (3 months ago) • Edgar (US Regulatory)

More Sangamo Therapeutics Inc News Articles

Voip Pal Com (QB)

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Digital Brand Media and ... (PK)

Northwest Biotherapeutics (QB)

Ubiquitech Software (PK)

Elite Pharmaceuticals (QB)

Lightwave Logic

CyberFuels (PK)

Anavex Life Sciences

Rennova Health (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions